PRD Therapeutics received the “JHVS2022 Venture Award – Special Jury Award”
PRD Therapeutics received the “JHVS2022 Venture Award – Special Jury Award” as a venture with especially high potential for practical use in the “JHVS SHOWCASE” held at the Japan Healthcare Venture Summit (JHVS) 2022 hosted by the Ministry of Health, Labour and Welfare.
We are pleased that our new anti-cholesterol product, PRD001, has been recognized as a high potential for the treatment of Rare Diseases and NASH/NAFLD.